ProQR Therapeutics N.V. PRQR
$ 2.69
3.86%
Annual report 2023
added 12-21-2024
ProQR Therapeutics N.V. Financial Ratios 2011-2024 | PRQR
Annual Financial Ratios ProQR Therapeutics N.V.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | - | -1.1 | -4.0 | -5.2 | -12.3 | -1.9 | -2.1 | -5.0 | -15.6 | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
- | - | -1.0 | -0.9 | -1.4 | -1.1 | -1.7 | -1.7 | -0.9 | - | - | - | - |
EV (Enterprise Value) |
-22.4 M | 11.4 M | -22.5 M | 154 M | 203 M | 366 M | 50.7 M | 50.1 M | 38.5 M | 228 M | 4.59 M | 239 K | - |
EBITDA per Share |
- | - | -0.89 | -1.03 | -1.4 | -1.07 | -1.6 | -1.65 | -1.14 | -1.47 | - | - | - |
EV/EBITDA |
0.5 | -3.3 | -3.5 | -11.6 | -1.0 | -1.1 | -1.2 | -6.9 | - | - | - | ||
PEG |
- | 0.12 | -1.52 | -1.53 | 0.32 | -0.66 | -0.02 | 0.27 | -0.02 | - | - | - | |
P/B |
- | - | 0.6 | 3.3 | 3.1 | 4.9 | 2.2 | 1.5 | 1.2 | 1.7 | - | - | - |
P/CF |
- | - | -2.6 | -4.0 | -6.6 | -15.9 | -2.4 | -2.6 | -4.8 | -14.2 | - | - | - |
ROE % |
- | - | -54.47 | -82.35 | -60.19 | -39.81 | -110.97 | -73.59 | -23.20 | -11.08 | - | - | - |
ROA % |
- | - | -29.43 | -47.16 | -48.05 | -33.47 | -82.17 | -59.66 | -20.81 | -10.52 | - | - | - |
ROCE % |
- | - | -50.51 | -47.91 | -53.92 | -35.56 | -90.78 | -67.60 | -28.59 | -14.67 | - | - | - |
Current Ratio |
1.4 | 1.6 | 2.2 | 2.3 | 5.0 | 6.3 | 3.9 | 9.2 | 17.8 | 37.8 | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in EUR currency
Quarterly Financial Ratios ProQR Therapeutics N.V.
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | - | - | -0.2 | -0.26 | -0.22 | -0.24 | -0.25 | -0.26 | -0.26 | -0.08 | -0.32 | -0.39 | -0.31 | -0.3 | -0.36 | - | -0.18 | -0.23 | - | - | - | -0.47 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | -0.24 | -0.24 | -0.21 | -0.2 | -0.24 | -0.23 | -0.22 | -0.07 | -0.33 | -0.37 | -0.35 | -0.3 | -0.38 | - | -0.18 | -0.24 | - | - | - | -0.42 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-28.84 | -44.95 | -42.30 | -55.70 | -66.94 | -74.22 | -81.82 | -73.60 | -67.70 | -64.11 | -65.26 | -76.79 | -74.65 | -60.70 | -46.03 | -61.88 | -38.41 | -38.41 | -63.45 | -61.79 | -61.79 | -30.89 | -30.89 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-15.19 | -23.90 | -24.01 | -33.72 | -39.52 | -44.21 | -48.47 | -29.77 | -45.29 | -47.70 | -50.77 | -59.36 | -43.85 | -28.04 | -32.71 | -39.42 | -39.42 | -19.71 | -19.71 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-33.81 | -43.33 | -37.80 | -49.03 | -56.73 | -60.41 | -64.99 | -57.98 | -53.63 | -56.79 | -63.46 | -76.10 | -74.07 | -63.50 | -46.65 | -63.53 | -39.51 | -39.51 | -61.41 | -55.35 | -55.35 | -27.67 | -27.67 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | 2.1 | 2.2 | 2.9 | 3.6 | - | 2.3 | 2.6 | 6.7 | 4.7 | 5.0 | 3.8 | 4.5 | - | 6.3 | - | 2.5 | - | 3.9 | - | - | - | 5.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in EUR currency